Transforming MLR Processes with AI Innovations

This white paper outlines the evolving role of Medical, Legal, and Regulatory (MLR) teams in the biopharmaceutical industry, emphasizing the integration of artificial intelligence (AI) to enhance content operations. It describes the challenges faced by content teams, including the late involvement of reviewers and the increasing volume of materials that often go unused. The document details various process improvements, such as claims management, content reuse, tier-based reviews, and content similarity, which aim to streamline the MLR review cycle. It highlights the necessity for collaboration among stakeholders early in the content lifecycle to produce higher-quality outputs. Furthermore, the paper discusses the potential economic impact of AI in the sector and the importance of maintaining compliance with regulatory standards during the transformation. The insights presented aim to guide organizations in leveraging AI effectively while ensuring that human oversight remains a critical component of the MLR review process.